These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Contribution of activated macrophages to the process of delayed xenograft rejection. Lin Y; Vandeputte M; Waer M Transplantation; 1997 Dec; 64(12):1677-83. PubMed ID: 9422401 [TBL] [Abstract][Full Text] [Related]
30. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143 [TBL] [Abstract][Full Text] [Related]
31. Deoxyspergualin delays xenograft rejection in the guinea pig-to-C6-deficient rat heart transplantation model. Wu GS; Korsgren O; Wennberg L; Tibell A Transpl Int; 1999; 12(6):415-22. PubMed ID: 10654352 [TBL] [Abstract][Full Text] [Related]
33. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats. Fryer JP; Chen S; Johnson EM; Simone P; Sun LH; Goswitz JJ; Matas AJ Transplant Proc; 1996 Apr; 28(2):700. PubMed ID: 8623353 [No Abstract] [Full Text] [Related]
34. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep. Rajasinghe HA; Reddy VM; Hancock WW; Sayegh MH; Hanley FL Transplantation; 1996 Aug; 62(3):407-11. PubMed ID: 8779691 [TBL] [Abstract][Full Text] [Related]
35. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts. Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695 [TBL] [Abstract][Full Text] [Related]
36. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of corneal xenograft rejection in a discordant species combination. Ross JR; Howell DN; Sanfilippo FP Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2469-76. PubMed ID: 8325753 [TBL] [Abstract][Full Text] [Related]
38. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031 [TBL] [Abstract][Full Text] [Related]
39. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. Hansen AB; Kirkeby S; Aasted B; Dahl K; Hansen AK; Dieperink H; Svendsen M; Kemp E; Buschard K; D'Apice AJ APMIS; 2003 Nov; 111(11):1019-26. PubMed ID: 14629268 [TBL] [Abstract][Full Text] [Related]
40. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway. Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]